Parallax buys pharmacy services firm

Parallax Health Sciences (PRLX +45.5%) acquires T.H.E. Pharmacy for $20M plus a 9.9% stake in PRLX. The transaction includes the payment of $15M in cash and a $5M promissory note.

T.H.E. Pharmacy generated $55M in revenues and $16M in EBIT in 2013.

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs